How is Anidulafungin administered?

Anidulafungin is an antifungal agent that belongs to the echinocandin class, primarily used to treat invasive fungal infections, particularly those caused by Candida species and Aspergillus species. Its method of administration is intravenous, which allows for direct delivery into the bloodstream and ensures proper absorption and bioavailability in systemic conditions, particularly in critically ill patients.

Intravenous administration is advantageous in a clinical setting because it provides immediate systemic therapy, which is essential for treating severe or life-threatening infections. Anidulafungin is specifically designed for this route, as it is not effectively absorbed in the gastrointestinal tract, making oral administration unsuitable. Thus, choosing intravenous delivery aligns well with the pharmacokinetics of the drug, ensuring that it reaches therapeutic concentrations quickly in the body.